Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.

Woffindale C, Riera NG, Wood MJA, Varela MA

Open source

DOI
10.1016/j.omtn.2026.102848
Published
2026 Mar 12
Container
Molecular therapy. Nucleic acids
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2026.102848,
  title = {Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.},
  author = {Woffindale C and Riera NG and Wood MJA and Varela MA},
  year = {2026},
  journal = {Molecular therapy. Nucleic acids},
  doi = {10.1016/j.omtn.2026.102848},
  url = {https://doi.org/10.1016/j.omtn.2026.102848}
}

RIS

TY  - JOUR
TI  - Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.
AU  - Woffindale C
AU  - Riera NG
AU  - Wood MJA
AU  - Varela MA
PY  - 2026
JO  - Molecular therapy. Nucleic acids
DO  - 10.1016/j.omtn.2026.102848
UR  - https://doi.org/10.1016/j.omtn.2026.102848
ER  - 

APA

C, W., NG, R., MJA, W., & MA, V. (2026). Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2026.102848

Source records